vaccines
GSK claims superiority for Cervarix in head-to-head trial
May 11, 2009Research and Development, Sales and Marketing GSK, vaccines
GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …
Consortium wins US biodefence contract
April 3, 2009Manufacturing and Production biologics, vaccines
A consortium of US and UK companies has been awarded an $11 million grant from the US Government to speed …
Cervical cancer awareness is Jade’s legacy
March 31, 2009Sales and Marketing NHS, vaccines
Jade Goody has left a legacy of hugely increased awareness of cervical cancer in the UK, following her death from …
Cervarix adverse reactions as expected, says MHRA
March 11, 2009Sales and Marketing GSK, vaccines
The government has played down reports about adverse reactions to GlaxoSmithKline's Cervarix, saying they are in line with expectations. The …
Novartis boosts vaccine pipeline
January 8, 2009Research and Development, Sales and Marketing Novartis, recruitment, vaccines
Novartis has added an investigational vaccine to its pipeline through a $20 million deal with AlphaVax. The North Carolina-based biotech …
Gardasil and Cervarix share innovation prize
September 25, 2008Sales and Marketing Cancer, Gardasil, prix galien, vaccines
Rival vaccine products that will prevent thousands of women developing cervical cancer have been declared joint winners of the prestigious …
Scottish schools first to deliver new cancer jab
September 1, 2008Sales and Marketing Scotland, vaccines
Scotland's secondary schools will this week become the first in the UK to vaccinate female students against cervical cancer. It …
Sanofi and Acambis to collaborate on West Nile virus
November 13, 2007Sales and Marketing vaccines
Acambis has struck a deal with Sanofi Pasteur to co-develop and co-market a vaccine for West Nile disease, a serious …
Gates Foundation could rival pharma, analysts warn
May 15, 2007Sales and Marketing Gates Foundation, HIV, TB, vaccines
The pharmaceutical industry could suffer a blow to its reputation, and could even suffer commercially, if it fails to appreciate …
Pfizer buys British vaccine company PowderMed
October 12, 2006Research and Development Pfizer, Powdermed, vaccines
Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in …
Immunisation factfile launched to promote 5-in-1 jab
October 13, 2004France, MMR, public health, vaccines
Aventis Pasteur MSD has collaborated with public health bodies in producing a Factfile in support of the company’s new 5-in-1 …
